Home | Business News | Browse by Publication | F | FDA Consumer

Celebrex approved for juvenile arthritis.

Publication: FDA Consumer
Publication Date: 01-MAR-07
Format: Online
Delivery: Immediate Online Access
Full Article Title: Celebrex approved for juvenile arthritis.(Updates)

Article Excerpt
In December 2006, the FDA approved Celebrex (celecoxib) for a new use--relief of the signs and symptoms of juvenile rheumatoid arthritis (IRA) in patients ages 2 years and older. Celebrex, a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID), was originally approved in 1998 for rheumatoid arthritis and osteoarthritis in adults....

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
Generic version of Wellbutrin XL.(Updates)(drug for the treatment of m..., March 01, 2007
First generic of Zofran.(Updates)(SICOR Pharmaceuticals Inc.; Kali Lab..., March 01, 2007
New drug for schizophrenia.(Updates)(Invega (paliperidone) extended-re..., March 01, 2007
Test screens blood for parasitic infection.(Updates)(ORTHO T. cruzi EL..., March 01, 2007
Heart disease deaths in American women decline.(Research Notebook), March 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.